Replies to post #134559 on Biotech Values

[dav1234]

who's next on the HCV uber premium buyout gravy train? ACHN ,IDIX , FURX ?

i see Medivir has a phase3 in HCV, J&J partner i believe?

[kris_kade]

Looks like lot of INHX doubters have bitten the dust. half truth is always dangerous.

[Biowatch]

BMY/INHX Didn't take long for lawsuit filing:

NEW YORK , Jan. 8, 2012 /PRNewswire/ -- The Law Office of James C. Kelly announces that it is investigating potential claims against the board of directors of Inhibitex, Inc. ("Inhibitex" or the "Company") (NasdaqCM: INHX - News) concerning possible breaches of fiduciary duty and other violations of law related to the Company's entry into an agreement to be acquired by Bristol-Myers Squibb Company ("Bristol-Myers") in a transaction with an approximate value of $2.5 billion .
Under the proposed agreement, Bristol-Myers will commence a tender offer to acquire all of the outstanding shares of Inhibitex's common stock at a price of $26.00 per share in cash.
The investigation concerns whether Inhibitex's board of directors adequately shopped the Company to obtain the best price possible for the Company's shareholders before entering into the agreement with Bristol-Myers.

http://finance.yahoo.com/news/The-Law-Office-James-C-Kelly-prnews-496132984.html

[jbog]

We probably should consider the premium paid for AnorMed Inc. because that stock went from the $4's to the final $13.50 with multiple bids unsolicited bids from both Millennium and Genzyme in 2006.